Brief: Glenmark Life Sciences Q4 Revenue From Operations At 6,213 Million Rupees, Up 21% YoY

Alivus Life Sciences

27/04/2023 13:14

April 27 (Reuters) - Glenmark Life Sciences Ltd  GLEM.NS :
    * Q4 REVENUE FROM OPERATIONS AT 6,213 MILLION RUPEES, UP 21% YOY
    * MARCH-QUARTER PROFIT 1.46 BILLION RUPEES VERSUS 989 MILLION RUPEES

Source text for Eikon:  ID:nBSE9Mc7tL 
Further company coverage:  GLEM.NS 

 ((Reuters.Briefs@thomsonreuters.com;))